secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001829126-25-008959
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc to host Nov 12 call to update on NEO100-1 trial and compassionate use data
--------------------------------------------------------------------------------

- Investor call on Nov 12, 2025 at 9:00 a.m. ET to present data updates from Phase 1/2a NEO100-1 trial.
- Discussion to include MRI radiographic response, progression-free survival (PFS), and overall survival (OS) trends.
- Participants include Duke and NYU Langone neuro-oncologists; management team present.
- No specific clinical results disclosed in the press release; call may provide new data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625008959/0001829126-25-008959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625008959/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-008959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer